Education
About Us
Working with TipRanks
Follow Us
InnovAge Holding (INNV)
NASDAQ:INNV
Earnings Data
Report Date
Sep 16, 2025TBA Not Confirmed
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.01Last Year’s EPS
-0.01Same Quarter Last Year
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 06, 2025
|% Change Since: 38.95%
|Next Earnings Date:Sep 16, 2025
Earnings Call Sentiment|Neutral
InnovAge reported strong revenue growth and improved adjusted EBITDA, along with successful operational transformation efforts. However, the company also faced increased net losses and corporate expenses, alongside challenges with new center operations.Company Guidance
During the InnovAge Third Quarter 2025 Earnings Conference Call, the company reaffirmed its fiscal year 2025 guidance, projecting an ending census between 7,300 and 7,750 participants, with member months ranging from 86,000 to 89,000. The total revenue is expected to be between $815 million and $865 million, while adjusted EBITDA is projected to be in the range of $24 million to $31 million. De novo losses are anticipated to be between $18 million and $20 million for fiscal 2025. The third quarter results showed a revenue of $218.1 million, a 13% year-over-year increase, and an adjusted EBITDA of $10.8 million, reflecting a 4.9% margin. The company experienced a 10% annual growth in census, reaching approximately 7,530 participants. Center-level contribution was $40.7 million, with an 18.7% margin, improving by approximately 110 basis points year-over-year. Despite challenges in the healthcare environment, InnovAge reported disciplined cost management and effective medical expense control, maintaining strong cost discipline amidst seasonal illness pressures.Strong Revenue Growth
InnovAge reported revenue of $218.1 million, representing a 13% increase year-over-year.
Improved Adjusted EBITDA
Adjusted EBITDA was $10.8 million, a significant improvement from $3 million in the previous year, with an adjusted EBITDA margin of 4.9%.
Census Growth
Census grew to approximately 7,530 participants, marking a 10% annual increase.
Operational Transformation
InnovAge has shifted from operational stabilization to enterprise transformation, with a focus on operational excellence and greater efficiency.
Pharmacy Initiative Success
The acquisition of a pharmacy in Colorado was completed, with the transition of pharmacy distribution and management successfully migrated.
Cost Management
Despite seasonal illness pressures, external provider costs were maintained, and PMPM spending declined from $4,857 in Q2 to $4,786 in Q3.
---
INNV Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
INNV Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 06, 2025 | $2.85 | $3.26 | +14.39% |
Feb 04, 2025 | $3.69 | $3.36 | -8.94% |
Nov 05, 2024 | $6.07 | $6.30 | +3.79% |
Sep 10, 2024 | $6.18 | $5.78 | -6.47% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does InnovAge Holding (INNV) report earnings?
InnovAge Holding (INNV) is schdueled to report earning on Sep 16, 2025, TBA Not Confirmed.
What is InnovAge Holding (INNV) earnings time?
InnovAge Holding (INNV) earnings time is at Sep 16, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is INNV EPS forecast?
INNV EPS forecast for the fiscal quarter 2025 (Q4) is -0.01.
---